Company Filing History:
2 out of 576 
1 out of 61 
1 out of 1 Years Active: 2007-2014
Title: Innovations by Judit Erchegyi in Somatostatin Research
Introduction
Judit Erchegyi is a prominent inventor located in San Diego, CA, known for her significant contributions to the field of biomedical research, particularly in somatostatin receptor antagonists. With a total of four patents to her name, her work has impacted the diagnosis and treatment of various diseases, showcasing the importance of innovation in pharmacology.
Latest Patents
Judit's latest patents focus on somatostatin receptor 2 (SSTR2) antagonists. The invention directed to somatostatin analogs comprises receptor-selective antagonists, particularly sst2-selective antagonists. These compounds are not only pivotal for therapeutic applications but also include formulations complexed with radioactive nuclides. This ligand-based invention provides methods and kits for both diagnosing and treating neoplastic and non-neoplastic mammalian diseases. Additionally, the receptor-selective somatostatin antagonists developed by Judit exhibit high affinity for the human SSTR2 receptor while avoiding unwanted side effects typically associated with other receptors such as SSTR1, SSTR3, SSTR4, or SSTR5. By incorporating radioiodine into these antagonists, they become valuable tools for drug-screening and therapeutic applications, blocking physiological effects mediated by SSTR2.
Career Highlights
Judit has made notable advancements during her career, working with leading research institutions like the Salk Institute for Biological Studies. Her innovative approaches and insights into somatostatin receptor interactions have gathered recognition in the pharmaceutical and biomedical communities.
Collaborations
Throughout her career, Judit has collaborated with esteemed colleagues, including Jean E F Rivier and Jean Claude Reubi. These partnerships have undoubtedly enriched her research endeavors, paving the way for advancements in somatostatin receptor antagonism.
Conclusion
Judit Erchegyi stands out as an influential inventor whose work on somatostatin receptor 2 antagonists holds promise for future therapeutic strategies. Her patents reflect a commitment to innovation and improvement in medical science, contributing to better diagnosis and treatment options for patients. Her career serves as an inspiration for aspiring inventors and researchers in the field of biomedicine.